Metabolomic profiling of portal blood and bile reveals metabolic signatures of primary sclerosing cholangitis

Pamela S. Tietz-Bogert, Minsuk Kim, Angela Cheung, James H. Tabibian, Julie K. Heimbach, Charles B. Rosen, Madhumitha Nandakumar, Konstantinos N Lazaridis, Nicholas F La Russo, Jaeyun Sung, Steven P. O’hara

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Primary sclerosing cholangitis (PSC) is a pathogenically complex, chronic, fibroinflammatory disorder of the bile ducts without known etiology or effective pharmacotherapy. Emerging in vitro and in vivo evidence support fundamental pathophysiologic mechanisms in PSC centered on enterohepatic circulation. To date, no studies have specifically interrogated the chemical footprint of enterohepatic circulation in PSC. Herein, we evaluated the metabolome and lipidome of portal venous blood and bile obtained at the time of liver transplantation in patients with PSC (n = 7) as compared to individuals with noncholestatic, end-stage liver disease (viral, metabolic, etc. (disease control, DC, n = 19)) and to nondisease controls (NC, living donors, n = 12). Global metabolomic and lipidomic profiling was performed on serum derived from portal venous blood (portal serum) and bile using ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and differential mobility spectroscopy-mass spectroscopy (DMS-MS; complex lipid platform). The Mann–Whitney U test was used to identify metabolites that significantly differed between groups. Principal-component analysis (PCA) showed significant separation of both PSC and DC from NC for both portal serum and bile. Metabolite set enrichment analysis of portal serum and bile demonstrated that the liver-disease cohorts (PSC and DC) exhibited similar enrichment in several metabolite categories compared to NC. Interestingly, the bile in PSC was uniquely enriched for dipeptide and polyamine metabolites. Finally, analysis of patient-matched portal serum and biliary metabolome revealed that these biological fluids were more homogeneous in PSC than in DC or NC, suggesting aberrant bile formation and enterohepatic circulation. In summary, PSC and DC patients exhibited alterations in several metabolites in portal serum and bile, while PSC patients exhibited a unique bile metabolome. These specific alterations in PSC are amenable to hypothesis testing and, potentially, therapeutic pharmacologic manipulation.

Original languageEnglish (US)
Article number3188
JournalInternational Journal of Molecular Sciences
Volume19
Issue number10
DOIs
StatePublished - Oct 16 2018

Fingerprint

Sclerosing Cholangitis
Metabolomics
metabolites
Bile
serums
blood
Blood
direct current
Metabolites
signatures
liver
Liver
Enterohepatic Circulation
viral diseases
Metabolome
mass spectroscopy
blood serum
Serum
etiology
transplantation

Keywords

  • Bile
  • Enterohepatic circulation
  • Metabolomics
  • Portal venous blood
  • Primary sclerosing cholangitis (PSC)

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Tietz-Bogert, P. S., Kim, M., Cheung, A., Tabibian, J. H., Heimbach, J. K., Rosen, C. B., ... O’hara, S. P. (2018). Metabolomic profiling of portal blood and bile reveals metabolic signatures of primary sclerosing cholangitis. International Journal of Molecular Sciences, 19(10), [3188]. https://doi.org/10.3390/ijms19103188

Metabolomic profiling of portal blood and bile reveals metabolic signatures of primary sclerosing cholangitis. / Tietz-Bogert, Pamela S.; Kim, Minsuk; Cheung, Angela; Tabibian, James H.; Heimbach, Julie K.; Rosen, Charles B.; Nandakumar, Madhumitha; Lazaridis, Konstantinos N; La Russo, Nicholas F; Sung, Jaeyun; O’hara, Steven P.

In: International Journal of Molecular Sciences, Vol. 19, No. 10, 3188, 16.10.2018.

Research output: Contribution to journalArticle

Tietz-Bogert, Pamela S. ; Kim, Minsuk ; Cheung, Angela ; Tabibian, James H. ; Heimbach, Julie K. ; Rosen, Charles B. ; Nandakumar, Madhumitha ; Lazaridis, Konstantinos N ; La Russo, Nicholas F ; Sung, Jaeyun ; O’hara, Steven P. / Metabolomic profiling of portal blood and bile reveals metabolic signatures of primary sclerosing cholangitis. In: International Journal of Molecular Sciences. 2018 ; Vol. 19, No. 10.
@article{272a4d8911bb44f2a2096e82d58a89b5,
title = "Metabolomic profiling of portal blood and bile reveals metabolic signatures of primary sclerosing cholangitis",
abstract = "Primary sclerosing cholangitis (PSC) is a pathogenically complex, chronic, fibroinflammatory disorder of the bile ducts without known etiology or effective pharmacotherapy. Emerging in vitro and in vivo evidence support fundamental pathophysiologic mechanisms in PSC centered on enterohepatic circulation. To date, no studies have specifically interrogated the chemical footprint of enterohepatic circulation in PSC. Herein, we evaluated the metabolome and lipidome of portal venous blood and bile obtained at the time of liver transplantation in patients with PSC (n = 7) as compared to individuals with noncholestatic, end-stage liver disease (viral, metabolic, etc. (disease control, DC, n = 19)) and to nondisease controls (NC, living donors, n = 12). Global metabolomic and lipidomic profiling was performed on serum derived from portal venous blood (portal serum) and bile using ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and differential mobility spectroscopy-mass spectroscopy (DMS-MS; complex lipid platform). The Mann–Whitney U test was used to identify metabolites that significantly differed between groups. Principal-component analysis (PCA) showed significant separation of both PSC and DC from NC for both portal serum and bile. Metabolite set enrichment analysis of portal serum and bile demonstrated that the liver-disease cohorts (PSC and DC) exhibited similar enrichment in several metabolite categories compared to NC. Interestingly, the bile in PSC was uniquely enriched for dipeptide and polyamine metabolites. Finally, analysis of patient-matched portal serum and biliary metabolome revealed that these biological fluids were more homogeneous in PSC than in DC or NC, suggesting aberrant bile formation and enterohepatic circulation. In summary, PSC and DC patients exhibited alterations in several metabolites in portal serum and bile, while PSC patients exhibited a unique bile metabolome. These specific alterations in PSC are amenable to hypothesis testing and, potentially, therapeutic pharmacologic manipulation.",
keywords = "Bile, Enterohepatic circulation, Metabolomics, Portal venous blood, Primary sclerosing cholangitis (PSC)",
author = "Tietz-Bogert, {Pamela S.} and Minsuk Kim and Angela Cheung and Tabibian, {James H.} and Heimbach, {Julie K.} and Rosen, {Charles B.} and Madhumitha Nandakumar and Lazaridis, {Konstantinos N} and {La Russo}, {Nicholas F} and Jaeyun Sung and O’hara, {Steven P.}",
year = "2018",
month = "10",
day = "16",
doi = "10.3390/ijms19103188",
language = "English (US)",
volume = "19",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - Metabolomic profiling of portal blood and bile reveals metabolic signatures of primary sclerosing cholangitis

AU - Tietz-Bogert, Pamela S.

AU - Kim, Minsuk

AU - Cheung, Angela

AU - Tabibian, James H.

AU - Heimbach, Julie K.

AU - Rosen, Charles B.

AU - Nandakumar, Madhumitha

AU - Lazaridis, Konstantinos N

AU - La Russo, Nicholas F

AU - Sung, Jaeyun

AU - O’hara, Steven P.

PY - 2018/10/16

Y1 - 2018/10/16

N2 - Primary sclerosing cholangitis (PSC) is a pathogenically complex, chronic, fibroinflammatory disorder of the bile ducts without known etiology or effective pharmacotherapy. Emerging in vitro and in vivo evidence support fundamental pathophysiologic mechanisms in PSC centered on enterohepatic circulation. To date, no studies have specifically interrogated the chemical footprint of enterohepatic circulation in PSC. Herein, we evaluated the metabolome and lipidome of portal venous blood and bile obtained at the time of liver transplantation in patients with PSC (n = 7) as compared to individuals with noncholestatic, end-stage liver disease (viral, metabolic, etc. (disease control, DC, n = 19)) and to nondisease controls (NC, living donors, n = 12). Global metabolomic and lipidomic profiling was performed on serum derived from portal venous blood (portal serum) and bile using ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and differential mobility spectroscopy-mass spectroscopy (DMS-MS; complex lipid platform). The Mann–Whitney U test was used to identify metabolites that significantly differed between groups. Principal-component analysis (PCA) showed significant separation of both PSC and DC from NC for both portal serum and bile. Metabolite set enrichment analysis of portal serum and bile demonstrated that the liver-disease cohorts (PSC and DC) exhibited similar enrichment in several metabolite categories compared to NC. Interestingly, the bile in PSC was uniquely enriched for dipeptide and polyamine metabolites. Finally, analysis of patient-matched portal serum and biliary metabolome revealed that these biological fluids were more homogeneous in PSC than in DC or NC, suggesting aberrant bile formation and enterohepatic circulation. In summary, PSC and DC patients exhibited alterations in several metabolites in portal serum and bile, while PSC patients exhibited a unique bile metabolome. These specific alterations in PSC are amenable to hypothesis testing and, potentially, therapeutic pharmacologic manipulation.

AB - Primary sclerosing cholangitis (PSC) is a pathogenically complex, chronic, fibroinflammatory disorder of the bile ducts without known etiology or effective pharmacotherapy. Emerging in vitro and in vivo evidence support fundamental pathophysiologic mechanisms in PSC centered on enterohepatic circulation. To date, no studies have specifically interrogated the chemical footprint of enterohepatic circulation in PSC. Herein, we evaluated the metabolome and lipidome of portal venous blood and bile obtained at the time of liver transplantation in patients with PSC (n = 7) as compared to individuals with noncholestatic, end-stage liver disease (viral, metabolic, etc. (disease control, DC, n = 19)) and to nondisease controls (NC, living donors, n = 12). Global metabolomic and lipidomic profiling was performed on serum derived from portal venous blood (portal serum) and bile using ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and differential mobility spectroscopy-mass spectroscopy (DMS-MS; complex lipid platform). The Mann–Whitney U test was used to identify metabolites that significantly differed between groups. Principal-component analysis (PCA) showed significant separation of both PSC and DC from NC for both portal serum and bile. Metabolite set enrichment analysis of portal serum and bile demonstrated that the liver-disease cohorts (PSC and DC) exhibited similar enrichment in several metabolite categories compared to NC. Interestingly, the bile in PSC was uniquely enriched for dipeptide and polyamine metabolites. Finally, analysis of patient-matched portal serum and biliary metabolome revealed that these biological fluids were more homogeneous in PSC than in DC or NC, suggesting aberrant bile formation and enterohepatic circulation. In summary, PSC and DC patients exhibited alterations in several metabolites in portal serum and bile, while PSC patients exhibited a unique bile metabolome. These specific alterations in PSC are amenable to hypothesis testing and, potentially, therapeutic pharmacologic manipulation.

KW - Bile

KW - Enterohepatic circulation

KW - Metabolomics

KW - Portal venous blood

KW - Primary sclerosing cholangitis (PSC)

UR - http://www.scopus.com/inward/record.url?scp=85055080157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055080157&partnerID=8YFLogxK

U2 - 10.3390/ijms19103188

DO - 10.3390/ijms19103188

M3 - Article

C2 - 30332763

AN - SCOPUS:85055080157

VL - 19

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 10

M1 - 3188

ER -